Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by JMP Securities

ME Staff
-
0

Analyst Ratings For Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

Today, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock was downgraded by JMP Securities from Outperform to Market Perform.

There are 3 Hold Ratings, 1 Sell Ratings, 1 Buy Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) is Hold with a consensus target price of $5.03 per share, a potential 20.61% downside.

Some recent analyst ratings include

  • 11/7/2019-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by JMP Securities
  • 10/18/2019-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by Svb Leerink with a price target of $6.30
  • 10/18/2019-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Market Perform by Leerink Swann with a price target of $6.30
  • 5/3/2019-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) gets downgraded to Underweight by Barclays with a price target of $2.50
  • 3/7/2019-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) had its Outperform rating reiterated by William Blair
  • 2/8/2018-Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) has coverage initiated with a Neutral ➝ Neutral rating and $3.50 price target
  • On 10/16/2019 Joseph Truitt, CEO, sold 133,484 with an average share price of $6.37 per share and the total transaction amounting to $850,293.08.
  • On 11/20/2017 & Johnson Johnson, Major Shareholder, sold 18,367,346 with an average share price of $2.75 per share and the total transaction amounting to $50,510,201.50.
  • On 12/22/2016 Jason S Fisherman, Director, bought 10,000 with an average share price of $3.96 per share and the total transaction amounting to $39,600.00.
  • On 12/5/2016 Mary Kay Fenton, CFO, bought 2,500 with an average share price of $4.11 per share and the total transaction amounting to $10,275.00.
  • On 12/2/2016 Joel C Barrish, Insider, bought 2,500 with an average share price of $4.06 per share and the total transaction amounting to $10,150.00.
  • On 12/30/2015 David Apelian, insider, sold 10,000 with an average share price of $10.50 per share and the total transaction amounting to $105,000.00.
  • On 12/28/2015 Mary Kay Fenton, CFO, sold 43,500 with an average share price of $10.08 per share and the total transaction amounting to $438,480.00.

Recent Trading Activity for Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)
Shares of Achillion Pharmaceuticals, Inc. closed the previous trading session at 6.34 up +0.035 0.55% with 6.36 shares trading hands.